Login to Your Account

Complex Carbohydrates Come to Chemoresistance

Selectin Blocker Can Protect Blood Stem Cells from Chemo

By Anette Breindl
Science Editor

Wednesday, October 24, 2012
Researchers from the Australian Mater Medical Research Institute, the University of Brisbane and U.S. biotech company GlycoMimetics Inc. have reported new insights into how blood stem cells are activated by selectins, and how blocking that activation may be able to protect them from the effects of chemotherapy and radiation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription